New York, Jan 20, 2026, 09:34 EST — Regular session
Microsoft Corp (MSFT) shares climbed roughly 0.7% to $459.86 in early New York trading Tuesday after Bristol Myers Squibb announced a deal to deploy the software giant’s AI-powered radiology tools aimed at accelerating early lung cancer detection. The partnership will leverage U.S. Food and Drug Administration-cleared imaging algorithms—approved for clinical use—via Microsoft’s Precision Imaging Network, which already analyzes X-ray and CT scans at hospitals across the U.S. “We have envisioned a unique AI-enabled workflow” to help clinicians identify patients and direct them to care, said Alexandra Goncalves, vice president and head of digital health at Bristol Myers. Reuters
Wall Street is back after Monday’s holiday, but the mood is jittery. New tariff threats from U.S. President Donald Trump are rattling risk appetite. David Lundgren, chief market strategist at Little Harbor Advisors, put it simply: “We’re getting the weakness because the headlines are going to drive angst and concern about what the future holds.” Reuters
Why it matters now: Microsoft ranks among the largest stocks in key U.S. indexes and serves as a barometer for corporate investment in AI—whether companies are fully committing or merely experimenting. Deals integrating Microsoft’s AI tools into daily operations, such as in hospitals and clinics, are closely tracked to see if the company’s AI spending will boost consistent sales.
Tariff jitters rattled the sector in Europe Monday as Microsoft shares listed in Frankfurt dropped 2.2%, falling alongside Nvidia and Alphabet. The move followed Trump’s threat to expand tariffs on European nations amid tensions over Greenland.
In the U.S., concerns linger that trade tensions and volatile rate and growth forecasts will weigh on pricey mega-caps, regardless of positive company updates. Microsoft often moves in step with the wider “Magnificent Seven” group whenever macroeconomic news dominates the market.
Speaking at the World Economic Forum in Davos, Microsoft CEO Satya Nadella cautioned that the AI surge risks turning into a speculative bubble if its uptake remains limited to major tech companies and affluent nations, according to the Financial Times.
Microsoft is gearing up to release its fiscal 2026 second-quarter earnings after the market closes on Wednesday, Jan. 28. The company will host a webcast of the earnings call at 2:30 p.m. Pacific time, according to an official announcement.
Investors will zero in on any clues about Azure demand, AI-related booking trends, and the adoption speed of newer offerings like Copilot among enterprise clients. Microsoft’s remarks will be measured against cloud rivals Amazon and Alphabet, both vying for the same corporate spending.
Deals like the Bristol Myers partnership don’t always translate into steady revenue gains. Hospital budgets, data-privacy rules, and the real-world performance of algorithms can all stall rollouts, even if pilot programs show promise.
Traders are weighing deal news against a market still digesting politics and macro developments as they happen. The next key date is Microsoft’s earnings report on Jan. 28.
